As of the latest SEC filings, Drugs Made In America Acquisition Corp. (DMAA) is held by 7 institutional funds. The largest fund shareholder is First Trust Merger Arbitrage Fund (VARAX), holding an estimated $20,257,524.00 in market value, representing 1.28% of its portfolio.
Funds holding Drugs Made In America Acquisition Corp. (DMAA)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- DMAA
- CIK:
- 0002028614
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VARAX
First Trust Merger Arbitrage Fund
|
MF | Independent / Boutique | 1.28% | $20,257,524.00 | 1,929,288 | Mar 31, 2026 | May 22, 2026 |
|
MERIX
The Merger Fund
|
MF | Independent / Boutique | 0.69% | $17,089,495.50 | 1,627,571 | Mar 31, 2026 | May 29, 2026 |
|
FTMAX
First Trust Multi-Strategy Fund
|
MF | Independent / Boutique | 0.24% | $3,149,023.50 | 299,907 | Mar 31, 2026 | May 22, 2026 |
|
RIV
RiverNorth Opportunities Fund Inc.
|
CEF | Independent / Boutique | 0.32% | $1,050,000.00 | 100,000 | Mar 31, 2026 | May 28, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $477,249.84 | 45,648 | Feb 28, 2026 | Apr 24, 2026 |
|
-
JNL Multi-Manager Alternative Fund
|
ETF | Independent / Boutique | 0.03% | $263,193.00 | 25,066 | Mar 31, 2026 | May 28, 2026 |
|
WCFRX
Virtus Westchester Credit Event Fund
|
MF | Duff & Phelps / Virtus | 0.21% | $171,811.50 | 16,363 | Mar 31, 2026 | May 29, 2026 |
Advertisement (320x50)